Transposon-triggered innate immune response confers cancer resistance to the blind mole rat.
Yang ZhaoEna OreskovicQuanwei ZhangQuan LuAbbey GilmanYifei S LinJunyue HeZhizhong ZhengJ Yuyang LuJina LeeZhonghe KeJulia AblaevaMatthew J SweetSteve HorvathZhengdong ZhangEviatar NevoAndrei SeluanovVera GorbunovaPublished in: Nature immunology (2021)
Blind mole rats (BMRs) are small rodents, characterized by an exceptionally long lifespan (>21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). Cells and tissues of BMRs express very low levels of DNA methyltransferase 1. Following cell hyperplasia, the BMR genome DNA loses methylation, resulting in the activation of RTEs. Upregulated RTEs form cytoplasmic RNA-DNA hybrids, which activate the cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and humans. We propose that RTEs were co-opted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of the innate immune response. Activation of RTEs is a double-edged sword, serving as a tumor suppressor but contributing to aging in late life via the induction of sterile inflammation.
Keyphrases
- immune response
- cell death
- cell cycle arrest
- induced apoptosis
- circulating tumor
- cell proliferation
- papillary thyroid
- oxidative stress
- single molecule
- cell free
- pi k akt
- dendritic cells
- squamous cell
- nucleic acid
- stem cells
- endoplasmic reticulum stress
- squamous cell carcinoma
- single cell
- dna methylation
- skeletal muscle
- diabetic rats
- metabolic syndrome
- adipose tissue
- cell therapy
- endothelial cells
- genome wide
- bone marrow
- young adults
- high glucose
- circulating tumor cells